The GROWTH consortium, funded by the European Commission (2019-2023), is made up to train a new generation of researchers working on new pathological insights, biomarker diagnostics and personalized nutritional interventions for intestinal failure in neonates and preterm infants.
Academic and industry partners, covering various disciplines ranging from fundamental research to clinical paediatrics and analytical chemistry to organoid and gut-on-chip applications, have teamed up in the European Union.
GROWTH aims to set-up a new European platform that trains young scientists in the industry-led exploration of innovative routes to fully exploit the potential of early life nutrition to prevent inflammatory disease. GROWTH coordinates 8 individual research projects.
If you have any questions you can fill in the form or mail us directly: firstname.lastname@example.org.
In Crohn’s disease, formation of fistulas is a very painful manifestation of the disease which is difficult to treat. The Tytgat group set-up a unique collaboration entitled “AMFIBIO” with Prof.dr. Geert D’Haens, Dr. Krisztina Gecse and Christianne Buskens, from the IBD Center and Clinical Genetics and Surgery departments of the Amsterdam University Medical Center. Together they will molecularly map out the problem of fistula formation and ultimately eliminate Crohn’s disease.
A large research grant is provided by The Leona M. and Harry B. Helmsley Charitable Trust in New York that will enable this study of the cells that cause Crohn’s disease fistula formation by means of specific single cell sequencing technology, and explore novel therapies. They can also follow why therapy works in some patients and not in others.
Thu, 21 January